KELLS, a Canadian-founded dental AI company, has secured Health Sciences Authority (HSA) registration in Singapore for its AI Dental Scan — making it the first consumer-facing AI dental screening tool to receive Class B medical device clearance in that market. As of September 2026, the milestone signals a turning point in how AI-assisted oral health screening is moving from the operatory to the smartphone, and Canadian dental professionals should pay attention.
As of September 2026, the global conversation around artificial intelligence in dentistry has shifted from "if" to "how fast." While most dental AI tools to date have targeted clinicians — think intraoral radiograph analysis, caries detection overlays, and treatment planning assistants — KELLS' latest regulatory win represents something structurally different: an AI tool designed for patients to use directly, outside the dental office, with nothing more than a smartphone camera.
What Happened: KELLS AI Dental Scan Gets Singapore HSA Registration
On September 16, 2026, KELLS announced that its AI Dental Scan had been registered as a Class B medical device with Singapore's Health Sciences Authority (HSA). According to the company, this makes it the first HSA-registered AI dental screening tool designed for direct consumer use in Singapore.
The tool works by allowing individuals to capture images of their teeth using a smartphone. KELLS' proprietary AI then analyzes these images to identify potential oral health concerns — conditions like visible caries, gingival inflammation, and plaque accumulation — and helps users understand their dental health status before they visit a dentist.
Class B medical device registration in Singapore is not trivial. It places the product in the same regulatory tier as diagnostic instruments and powered surgical tools, meaning KELLS had to demonstrate safety, performance, and quality management standards consistent with international frameworks like ISO 13485. For context, Singapore's HSA classification system is closely aligned with the Global Harmonization Task Force (GHTF) model that Health Canada also references.
Why This Matters Beyond Singapore
The significance of KELLS' HSA registration extends well beyond the Southeast Asian market. It establishes a regulatory precedent for consumer-facing dental AI — a product category that, until now, has existed in a grey zone between wellness app and medical device in most jurisdictions.
For Canadian dental professionals, there are several implications worth considering:
Health Canada's AI Medical Device Framework Is Evolving
Health Canada has been updating its guidance on software as a medical device (SaMD) and AI-based medical devices throughout 2026. The agency's framework distinguishes between AI tools that inform clinical decisions (which require medical device licensing) and those that provide general wellness information (which may not). A consumer AI screening tool that identifies potential caries or gingival disease sits squarely in a regulatory determination zone that Health Canada will eventually need to address explicitly for dental applications.
Canadian dentists should understand that if tools like the KELLS AI Dental Scan seek to enter the Canadian market, they would need to navigate Health Canada's medical device classification system — likely as a Class II device — and comply with the Medical Devices Regulations (SOR/98-282). The Royal College of Dental Surgeons of Ontario (RCDSO) would also need to provide guidance on how such tools interact with existing standards of care.
Patient-Initiated Screening Could Change Appointment Patterns
One of the most practical implications for practice owners is what happens when patients arrive having already received an AI-generated screening report. This is not hypothetical — it is already happening with general health AI tools and symptom checkers. Dental practices in the Greater Toronto Area that serve tech-savvy patient populations should prepare for consultations where the patient comes in with a smartphone-generated "oral health score" and expects the dentist to either confirm or explain it.
Pro Tip: Practices that proactively address AI screening tools in their patient communication — acknowledging their value as awareness builders while reinforcing that a clinical examination remains the gold standard — will build trust rather than defensiveness. Consider adding a brief section to your new-patient intake form asking whether the patient has used any oral health apps or AI screening tools.
The Competitive Landscape for Dental AI Is Accelerating
KELLS joins a growing roster of dental AI companies that have achieved regulatory clearances in 2026. Overjet has expanded its FDA-cleared radiograph analysis platform across more than 400 practices through Dental Care Alliance. Pearl's FDA-cleared platform now reports that untreated decay rates are 4.5 times higher than federal estimates. And multiple AI-powered orthodontic planning tools have received new clearances this year.
The difference with KELLS is the consumer-facing model. While most dental AI platforms are B2B tools designed for clinician use within existing practice workflows, KELLS is going directly to the patient. This distinction matters because it could fundamentally alter how patients enter the dental care system — shifting from periodic recall-based visits to AI-prompted, concern-driven appointments.
What Canadian Dentists Should Watch For
Several developments are worth monitoring as consumer dental AI matures:
- Regulatory harmonization: Singapore's HSA framework is broadly aligned with the Global Harmonization Task Force model. As more countries register consumer dental AI tools, pressure will build for Health Canada to provide explicit guidance on this product category.
- Insurance and benefits integration: The Canadian Dental Care Plan (CDCP) already faces capacity challenges. Consumer AI screening tools that identify dental needs in populations that previously avoided care could increase demand further — a dynamic that practice owners and provincial dental associations will need to address.
- Standard of care questions: If a patient uses an AI screening tool that flags a potential issue, and the patient's dentist disagrees with the AI's assessment, questions around documentation and standard of care will emerge. The RCDSO has not yet addressed this scenario in its practice guidelines.
- Liability considerations: Who bears responsibility if an AI screening tool provides a false negative — reassuring a patient that their oral health is satisfactory when a clinical examination would have identified pathology? This liability question is unresolved in most jurisdictions, including Ontario.
Pro Tip: Canadian Dental Association (CDA) position statements on digital health and AI are worth reviewing periodically. As regulatory developments accelerate internationally, the CDA is likely to update its guidance for member dentists on how to discuss AI screening tools with patients.
The Bigger Picture: AI Is Reshaping the Patient Journey
The KELLS milestone fits within a broader pattern reshaping how patients interact with dental care. AI imaging analysis, automated appointment scheduling, predictive treatment planning, and now consumer-facing screening — each step moves artificial intelligence deeper into the dental patient journey. For practice owners in Toronto, Mississauga, Brampton, Markham, and across the GTA, the practical question is not whether to adopt AI but how to integrate it in ways that enhance clinical outcomes and patient relationships.
The transition will not be instant. Regulatory frameworks need to catch up, clinical validation studies need to accumulate, and professional guidelines need to evolve. But the direction is clear: the patient of 2028 will arrive at your operatory door having already interacted with dental AI in some form. Practices that prepare for this reality now will be better positioned than those that wait for it to arrive.
EBIKO Dental will continue monitoring AI developments in Canadian dentistry and their implications for dental practice operations and infection prevention and control (IPAC) protocols.
Frequently Asked Questions
Q: What is KELLS AI Dental Scan and how does it work?
KELLS AI Dental Scan is a consumer-facing dental screening tool that uses smartphone photography and proprietary artificial intelligence to analyze images of teeth and identify potential oral health concerns. According to the manufacturer, users capture photos of their teeth, and the AI flags conditions like visible caries, gingival inflammation, and plaque accumulation. It is designed as a screening tool to prompt dental visits — not as a replacement for clinical examination and diagnosis by a licensed dentist.
Q: Is KELLS AI Dental Scan available in Canada?
As of September 2026, KELLS AI Dental Scan has received Class B medical device registration with Singapore's Health Sciences Authority (HSA). Its availability in Canada would require separate regulatory review by Health Canada under the Medical Devices Regulations. Canadian dental professionals should confirm Health Canada registration status before recommending any AI dental screening product to patients.
Q: How should Canadian dentists prepare for patients using AI dental screening tools?
Dental practices in Ontario and across Canada should prepare by understanding how consumer AI screening tools work, reviewing relevant Canadian Dental Association (CDA) and Royal College of Dental Surgeons of Ontario (RCDSO) guidance on digital health, and considering how to integrate patient-initiated screening reports into clinical workflows. Adding questions about AI tool usage to new-patient intake forms and training staff to discuss the distinction between AI screening and clinical diagnosis are practical first steps.